Mostrando 9 resultados de: 9
Publisher
Medicina (Argentina)(2)
Acta Tropica(1)
Emerging Infectious Diseases(1)
Frontiers in Cellular and Infection Microbiology(1)
Journal of Parasitology(1)
Área temáticas
Enfermedades(7)
Farmacología y terapéutica(3)
Medicina forense; incidencia de enfermedades(3)
Microorganismos, hongos y algas(3)
Ginecología, obstetricia, pediatría, geriatría(1)
Área de conocimiento
Infección(6)
Inmunología(3)
Farmacología(2)
Parasitología(2)
Descubrimiento de fármacos(1)
Origen
scopus(9)
Clinical and epidemiological features of leishmaniasis in northwestern-Argentina through a retrospective analysis of recent cases
ArticleAbstract: Leishmaniasis is a parasitic disease caused by hemoflagellates of the genus Leishmania and is transmPalabras claves:Cutaneous leishmaniasis, Leishmania (L.) amazonensis, Leishmania (L.) infantum, Leishmania (V.) braziliensis, Mucocutaneous leishmaniasis, Visceral leishmaniasisAutores:Alejandra Beatriz Barrio, Basombŕo M.A., Beckar J., Fabricio Miguel Locatelli, González-Prieto G., Hashiguchi Y., Jaime D., Jorge Diego Marco, María Celia Mora, María Fernanda García Bustos, Monroig S., Moreno S., Parodi C.M., Ramos F., Sajama J., Yeo M.Fuentes:scopusB-cell profile, B-cell activating factor concentration and IgG levels in human cutaneous and mucosal leishmaniasis
ArticleAbstract: Aims: The aim of this study was to evaluate characteristics of B cells in human tegumentary leismaniPalabras claves:B lymphocytes, B-cell activating factor, Cutaneous leishmaniasis, hypergammaglobulinemia, interferon-gamma, Interleukin-6, Mucocutaneous leishmaniasisAutores:Albareda M.C., Alejandra Beatriz Barrio, Badano N., Castro Eiro M.E., de Elizalde de Bracco M.M., González Prieto A.G., Laucella S.A., María Fernanda García Bustos, Parodi C.M., Pimentel J.Fuentes:scopusDevelopment of a Fluorescent Assay to Search New Drugs Using Stable tdTomato-Leishmania, and the Selection of Galangin as a Candidate With Anti-Leishmanial Activity
ArticleAbstract: Antimonials continue to be considered the first-line treatment for leishmaniases, but its use entailPalabras claves:flavonoids, Fluorescence, galangin, L. (L.) amazonensis, tdTomatoAutores:Buttazzoni Zuñiga V.C., Jorge Diego Marco, Manghera P., María Fernanda García Bustos, Moya Álvarez A., Paola Andrea Barroso, Parodi C.M., Pastrana O.M., Peñalva P.A., Pérez Brandán C., Sosa A.M.Fuentes:scopusAlterations of immunological parameters in an autochthonous case of visceral leishmaniasis from the northwest of Argentina
ArticleAbstract: We report the alterations of immunological parameters of a patient with visceral leishmaniasis causePalabras claves:B-lymphocyte differentiation, cytokines, T-lymphocyte differentiation, Visceral leishmaniasisAutores:Alejandra Beatriz Barrio, Basombŕo M.A., de Bracco M.M.d.E., María Celia Mora, María Fernanda García Bustos, Parodi C.M., Ramos F.Fuentes:scopusAmerican tegumentary leishmaniasis: T-cell differentiation profile of cutaneous and mucosal forms—co-infection with Trypanosoma cruzi
ArticleAbstract: American tegumentary leishmaniasis displays two main clinical forms: cutaneous (CL) and mucosal (ML)Palabras claves:Cutaneous leishmaniasis, Differentiation and memory phenotype, Leishmania–T. cruzi co-infection, Mucosal leishmaniasis, Peripheral T lymphocytesAutores:Alejandra Beatriz Barrio, Baré P., Basombŕo M.A., de Elizalde de Bracco M.M., González Prieto A.G., María Celia Mora, María Fernanda García Bustos, Parodi C.M., Ramos F.Fuentes:scopusIn vivo antileishmanial efficacy of miltefosine against Leishmania (Leishmania) amazonensis
ArticleAbstract: Leishmaniasis, a disease caused by parasites of the Leishmania genus, constitutes a significant healPalabras claves:Autores:Alejandra Beatriz Barrio, Basombŕo M.A., Cimino R.O., De Raspi E.M., María Fernanda García Bustos, Parada L.A., Parodi C.M., Prieto G.G., Rubén Marino Cardozo, Soto J., Uncos D.A., Yeo M.Fuentes:scopusMiltefosine versus meglumine antimoniate in the treatment of mucosal leishmaniasis
ArticleAbstract: The conventional treatment for tegumentary leishmaniasis is meglumine antimoniate, which needs parenPalabras claves:Leishmaniasis treatment, Miltefosine, Mucocutaneous leishmaniasisAutores:Alejandra Beatriz Barrio, Basombŕo M.A., Beckar J., María Fernanda García Bustos, Moreno S., Parodi C.M.Fuentes:scopusLeishmania infantum and human visceral leishmaniasis, Argentina
OtherAbstract:Palabras claves:Autores:Alberto G. Gentile, Alejandra Beatriz Barrio, Basombŕo M.A., Fabricio Miguel Locatelli, Hashiguchi Y., Jorge Diego Marco, Korenaga M., María Celia Mora, María Fernanda García Bustos, Parodi C.M.Fuentes:scopusRisk factors for antimony treatment failure in american cutaneous leishmaniasis in Northwestern-Argentina
ArticleAbstract: Background. To date, there is no specific literature available on the determinants for therapeutic fPalabras claves:Autores:Alejandra Beatriz Barrio, Beckar J., Delgado-Noguera L.A., González-Prieto G., Hashiguchi Y., Jaime D., Lemir C.G., María Celia Mora, María Fernanda García Bustos, Monroig S., Moreno S., Oliveira F., Pániz-Mondolfi A.E., Parodi C.M., Ramos F., Ruiz-Morales L.Fuentes:scopus